American drug policy focuses on "prevalence reduction," which aims to reduce or eliminate psychoactive drug use. A movement called "harm reduction" emerged during the 1980s as a strategy for dealing with harms unmitigated by traditional approaches. Harm reduction focuses on minimizing the adverse consequences of drug use through interventions such as needle exchange, "safe use" education, and the use of treatment as an alternative to incarceration.
Originally published in: The 1996 Wellness Lectures, 1996, pp. 5-27.
This report is part of the RAND Corporation reprint series. The Reprint was a product of the RAND Corporation from 1992 to 2011 that represented previously published journal articles, book chapters, and reports with the permission of the publisher. RAND reprints were formally reviewed in accordance with the publisher's editorial policy and compliant with RAND's rigorous quality assurance standards for quality and objectivity. For select current RAND journal articles, see External Publications.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.